Translation of "Contributions Agency " (English → French) :

Contributions Agency | CA [Abbr.]

EDA contributing party | European Defence Agency contributing party

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Agreement between the European Community, the European Space Agency and the European Organisation for the Safety of Air Navigation on a European Contribution to the development of a global navigation satellite system (GNSS)

executive agency [ Chafea | Consumers, Health, Agriculture and Food Executive Agency | EACEA | EACI | EAHC | EASME | Education, Audiovisual and Culture Executive Agency | ERCEA | European Research Council Executive Agency | Executive Agency for Competitiveness and Innovation | Executive Agency for Health and Consumers | Executive Agency for Small and Medium-sized Enterprises | INEA | Innovation and Networks Executive Agency | REA | Research Executive Agency | TEN-T EA | Trans-European Transport Network Executive Agency ]

Ad Hoc Committee of the General Assembly for the Announcement of Voluntary Contributions to the United Nations Relief and Works Agency for Palestine Refugees in the Near East

EU office or agency [ autonomous Community body | Community service body | decentralised Community body | EC institutional body | EC satellite body | EC specialised body | EU Agencies and decentralised bodies | European agency | European foundation | European Monitoring Centre | European Union office or agency | specialised Community agency ]

credit rating [ CRA | credit agency | credit assessment | credit rating agency | international rating agency | mercantile agency | Rating agency(STW) ]

Definition: This category differs from others in that it includes disorders identifiable on the basis of not only symptoms and course but also the existence of one or other of two causative influences: an exceptionally stressful life event producing an acute stress reaction, or a significant life change leading to continued unpleasant circumstances that result in an adjustment disorder. Although less severe psychosocial stress ( life events ) may precipitate the onset or contribute to the presentation of a very wide range of disorders classified elsewhere in this chapter, its etiological importance is not always clear and in each case wi ...[+++]ll be found to depend on individual, often idiosyncratic, vulnerability, i.e. the life events are neither necessary nor sufficient to explain the occurrence and form of the disorder. In contrast, the disorders brought together here are thought to arise always as a direct consequence of acute severe stress or continued trauma. The stressful events or the continuing unpleasant circumstances are the primary and overriding causal factor and the disorder would not have occurred without their impact. The disorders in this section can thus be regarded as maladaptive responses to severe or continued stress, in that they interfere with successful coping mechanisms and therefore lead to problems of social functioning.

Definition: This category should be used when two or more psychoactive substances are known to be involved, but it is impossible to assess which substance is contributing most to the disorders. It should also be used when the exact identity of some or even all the psychoactive substances being used is uncertain or unknown, since many multiple drug users themselves often do not know the details of what they are taking. | misuse of drugs NOS

1. The revenues of the Agency shall consist of a contribution from the Union budget, contributions from third countries participating in the work of the Agency as provided for in Article 30, and voluntary contributions from Member States in money or in kind.

In order to guarantee the full autonomy and independence of the Agency and to enable it to perform additional and new tasks, including unforeseen emergency tasks, the Agency should be granted a sufficient and autonomous budget whose revenue comes primarily from a contribution from the Union and contributions from third countries participating in the Agency’s work.

1. This Regulation establishes a European Union Agency for Network and Information Security (ENISA, hereinafter ‘the Agency’) to undertake the tasks assigned to it for the purpose of contributing to a high level of network and information security within the Union and in order to raise awareness of network and information security and to develop and promote a culture, of network and information security in society for the benefit of citizens, consumers, enterprises and public sector organisations in the Union, thus contributing to the ...[+++] establishment and proper functioning of the internal market.

15. Notes, that the contribution to the European Medicines Agency for 2015, as requested by the Agency and as adopted by the Commission amounts to EUR 31,516 million; is aware that to this amount, the 2013 outturn of EUR 1,499 million needs to be added, reaching a total contribution of EUR 33,015 million in 2015; points out that the proposed contribution does not cover any additional contribution relating to the implementation of the Pharmacovigilance legislation, as the costs of this activity are to be covered by fees; recalls that Regulation (EU) No ...[+++]658/2014 of the European Parliament and of the Council entered into force in July 2014 and that the Agency will have to adapt its existing human and financial resources to cover the Pharmacovigilance activities; stresses that the European Medicines Agency is one of the industry-driven agencies which, in the last four years, has not received one additional post for the implementation of the Pharmacovigilance legislation resulting in a slow-down of handling files;